ReviewFrontiers in pharmacology2025

An overview of mechanisms, biomarkers, and treatment strategies for acquired anti-EGFR resistance in RAS wild-type colorectal cancer.

Chenxiang Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.